JPS567724A - Blend and its manufacture - Google Patents

Blend and its manufacture

Info

Publication number
JPS567724A
JPS567724A JP7845280A JP7845280A JPS567724A JP S567724 A JPS567724 A JP S567724A JP 7845280 A JP7845280 A JP 7845280A JP 7845280 A JP7845280 A JP 7845280A JP S567724 A JPS567724 A JP S567724A
Authority
JP
Japan
Prior art keywords
water
blend
manufacture
pharmaceutical
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7845280A
Other languages
English (en)
Inventor
Mauraa Rooberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of JPS567724A publication Critical patent/JPS567724A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Medicines Containing Plant Substances (AREA)
JP7845280A 1979-06-21 1980-06-12 Blend and its manufacture Pending JPS567724A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792925009 DE2925009A1 (de) 1979-06-21 1979-06-21 Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
JPS567724A true JPS567724A (en) 1981-01-27

Family

ID=6073755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7845280A Pending JPS567724A (en) 1979-06-21 1980-06-12 Blend and its manufacture

Country Status (5)

Country Link
US (1) US4315002A (ja)
EP (1) EP0021009B1 (ja)
JP (1) JPS567724A (ja)
AT (1) ATE3814T1 (ja)
DE (2) DE2925009A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770786A (en) * 1981-11-30 1988-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Separation of organic liquid from mixture employing porous polymeric ultrafiltration membrane

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793336A (en) * 1981-03-25 1988-12-27 Wang Paul Y Wound coverings and processes for their preparation
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4642286A (en) * 1984-05-07 1987-02-10 Moldowan Mervin J Composition and method for ethanol determination
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5561121A (en) * 1993-11-09 1996-10-01 American Cyanamid Company Stable lyophilized thiotepa composition
FR2754183A1 (fr) * 1996-10-08 1998-04-10 Lefebvre Jean Marie Composition visqueuse hemostatique, notamment a l'etat de gel
IT1312110B1 (it) * 1999-05-18 2002-04-04 Istituto Biochimico Pavese Pha Addotti antibiotico-polimero polisaccaridico naturale
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
IT1319666B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibiotici con polimeri polisaccaridici naturali in formadi soluzioni acquose.
US6547812B1 (en) 2000-12-29 2003-04-15 Advanced Cardiovascular Systems, Inc. Radiation therapy using a radioactive implantable device and a radiosensitizer agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
CH621561A5 (en) * 1974-01-14 1981-02-13 Ceskoslovenska Akademie Ved Process for producing a bromocyan-activated, hydrophilic, polymeric carrier for biologically active compounds in dried form
DE2441761A1 (de) * 1974-08-30 1976-03-11 Kohjin Co Gefriergetrocknete 2,2'-anhydro1-beta-d-arabinofuranosylcytosinsalz-praeparate, verfahren zu ihrer herstellung und injektionspraeparat
JPS5247984A (en) * 1975-10-15 1977-04-16 Eisai Co Ltd Stabilization of elastase
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
CH621479A5 (ja) * 1977-08-05 1981-02-13 Battelle Memorial Institute

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770786A (en) * 1981-11-30 1988-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Separation of organic liquid from mixture employing porous polymeric ultrafiltration membrane

Also Published As

Publication number Publication date
EP0021009B1 (de) 1983-06-22
EP0021009A2 (de) 1981-01-07
ATE3814T1 (de) 1983-07-15
DE3063858D1 (en) 1983-07-28
EP0021009A3 (en) 1981-01-28
US4315002A (en) 1982-02-09
DE2925009A1 (de) 1981-01-08

Similar Documents

Publication Publication Date Title
JPS567724A (en) Blend and its manufacture
NZ228130A (en) Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
GB1405088A (en) Slow release formulation
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
ES439113A1 (es) Procedimiento para preparar productos farmaceuticos de pene-tracion a traves de la piel.
ES430431A1 (es) Varistor de oxido metalico.
UA34419C2 (uk) Ліофілізований препарат для ін'єкцій та спосіб інгібування росту пухлин
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
ES447803A2 (es) Procedimiento de obtencion de un activador del plasminogeno.
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
DK658387A (da) Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf
GB1484832A (en) Tablets
ES451058A1 (es) Un procedimiento de preparacion de un nuevo derivado de oxa-zol.
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
DE2963526D1 (en) Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid, especially for use as hypolipidemic agents, processes for their preparation, pharmaceutical compositions comprising them, tetrahydropyran-2,3,5-triones useful in the preparation of the said derivatives and a process for preparing these tetrahydropyran-2,3,5-triones
IL40685A0 (en) Pharmaceutical compositions for the dissolution of renal calculi and their preparation
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
PT74794A (en) Process for preparing oxazole derivatives
NL7416873A (nl) Werkwijze ter bereiding van farmaceutische pre- en met anti-allergische werking, de aldus egen gevormde voortbrengselen, alsmede ijze ter bereiding van 5:6-benzo-gamma derivaten.
ES412146A1 (es) Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
IL59295A (en) Dehydrophenylalanyl-tryptophan derivatives,their production and pharmaceutical compositions containing them
IL47334A (en) Pharmaceutical compositions for the treatment of parkinsonism, comprising l-dopa and cyproheptadine and their preparation
PT65737A (en) Voir,s.v.p.,le papier ci joint avec le titre "process for the preparation of disubstituted phenol ethers of 3-amino-2-hydroxypropane,with cerebrovascular activity,application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and application of these pharmaceutical compositions in the treatment of cerebrovascular insufficiency"
YU273475A (en) Process for obtaining 10,11-dihydro-3-carboxy-cyproheptadine